Medpace Holdings, Inc. (MEDP) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Diagnostics & Research industria. La empresa tiene su sede en Cincinnati, OH, United States. El CEO actual es August James Troendle.
MEDP tiene fecha de IPO 2016-08-11, 5,900 empleados a tiempo completo, cotiza en el NASDAQ Global Select, una capitalización de mercado de $14.85B.
Medpace Holdings, Inc. is a clinical research organization that provides comprehensive drug and medical device development services to pharmaceutical, biotechnology, and medical device companies across North America, Europe, and Asia. The company supports the entire clinical development lifecycle from Phase I through Phase IV trials, offering specialized services including clinical monitoring, regulatory affairs, data management, pharmacovigilance, and post-marketing support across multiple therapeutic areas. Medpace also provides specialized laboratory services including bio-analytical testing, clinical human pharmacology, imaging services, and electrocardiography support. Founded in 1992 and headquartered in Cincinnati, Ohio, the company serves as a trusted partner in advancing new drug and device candidates toward regulatory approval.
